Fact CheckerSign in

NCT05072587Completed

Dietary Oxysterols and β-Cell Function Among African Americans

Source: ClinicalTrials.gov · Last updated 17 Apr 2026

Brief summary (registry, in English)

African Americans (AAs) have a higher risk of developing type 2 diabetes than the general population. AAs are also more likely to eat foods that contain cholesterol oxides/oxysterols. Dietary oxysterols can harm the cells that produce insulin and decrease insulin production. This pilot study seeks to determine if removing dietary oxysterols with a plant-based diet will improve insulin production and decrease the risk of type 2 diabetes among AAs.

Status (registry)
Completed
Study type
Interventional
Enrollment
12 (actual)
First submitted
24 Sept 2021
Start date
1 Jul 2021
Primary completion date
31 Dec 2023
Lead sponsor
Morehouse School of Medicine
NCT number
NCT05072587

What you commit to

  • Study type: Interventional
  • Participants enrolled: 12
  • From 1 Jul 2021 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Be currently on a vegan, vegetarian, or any type of plant-based diet for the 3 months prior to recruitment: Participants currently on these diets may not see significant changes on the dietary interventions of the study protocol.

Other illness

  • Be on dialysis or have any stage of renal failure: Dialysis patients need special diets and more intense monitoring than is planned for the participants in this study.
  • Have food allergies: Participants will be screened for food allergies. This is to prevent food sensitivities or adverse reactions to the prepared meals in the study.

Lab values

  • Be taking statin medications or any other cholesterol lowering drugs or supplements: These medications may artificially lower serum cholesterol and oxysterol levels.
  • Be on medications or supplements to lower blood glucose or treat diabetes: This will be an effect modifier or confounding factor. We will not know the effect of the dietary intervention if the participants are also on medications for diabetes.
  • Be status post blood transfusion in the previous 3 months: This will interfere with the test for HbA1c levels. This is one of our primary outcomes:
  • Have a hemoglobin or any other blood disorder: This will interfere with the test for HBA1c which measures glycation of hemoglobin in red blood cells.:

Other

  • Be pregnant or lactating: Fetuses and breast-feeding infants are a protected vulnerable group. The risk of involving them in research must outweigh the benefits, Hormonal levels and other factors in pregnant and lactating woman may confound study results.
  • Be a current smoker: Smoking is a risk factor for oxidative stress - this could be an effect modifier or a confounding faction for this study.
  • Be taking biotin supplements: This interferes with the test for fasting C-Peptide.

Who the study is looking for

  • HbA1c: 5.7% - 7.0%: This HbA1c range reflects mild to moderate β-cell dysfunction.
  • Self-identified AA: This group has higher rates of T2D than the general population.
  • Adults over18 years old: This age group is at higher risk of T2D.
  • Ability to read, understand and communicate effectively in English: All information about the study and instructions for the study protocol will be in English.
  • Committed to eating the allocated study diet for 12 weeks: This is important to ensure that the study protocol is followed, and the data collected from participants is meaningful/valid.
  • On stable medication dosages for the three months prior to recruitment: This is to avoid bias or confounding with new medications or dosages changes.
  • Able to safely store a week's supply of prepared meals: Participants will receive packages of prepared food that has to stored and last them for the following week.
  • Mentally competent and able to follow the study protocol and provide informed consent
  • Currently eating the Standard American diet: The baseline diet of the participants will be assessed and correlated their baseline serum 7-KC levels and HOMA2 Index of β-cell function.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Morehouse School of Medicine
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.